Guneli Ensari, Cavdar Zahide, Islekel Huray, Sarioglu Sulen, Erbayraktar Serhat, Kiray Muge, Sokmen Selman, Yilmaz Osman, Gokmen Necati
Department of Laboratory Animal Sciences, Health Sciences Institute, Dokuz Eylul, University, Izmir, Turkey.
Mol Med. 2007 Sep-Oct;13(9-10):509-17. doi: 10.2119/2007-00032.Guneli.
Previous studies have shown that erythropoietin (EPO) has protective effects against ischemia/reperfusion (I/R) injury in several tissues. The aim of this study was to determine whether EPO could prevent intestinal tissue injury induced by I/R. Wistar rats were subjected to intestinal ischemia (30 min) and reperfusion (60 min). A single dose of EPO (5000 U/kg) was administered intraperitoneally at two different time points: either at five minutes before the onset of ischemia or at the onset of reperfusion. At the end of the reperfusion period, jejunum was removed for examinations. Myeloperoxidase (MPO), malondialdehyde (MDA), and antioxidant defense system were assessed by biochemical analyses. Histological evaluation was performed according to the Chiu scoring method. Endothelial nitric oxide synthase (eNOS) was demonstrated by immunohistochemistry. Apoptotic cells were determined by TUNEL staining. Compared with the sham, I/R caused intestinal tissue injury (Chiu score, 3+/-0.36 vs 0.4+/-0.24, P<0.01) and was accompanied by increases in MDA levels (0.747+/-0.076 vs 0.492+/-0.033, P<0.05), MPO activity (10.51+/-1.87 vs 4.3+/-0.45, P<0.05), intensity of eNOS immunolabelling (3+/-0.4 vs 1.3+/-0.33, P<0.05), the number of TUNEL-positive cells (20.4+/-2.6 vs 4.6+/-1.2, P<0.001), and a decrease in catalase activity (16.83+/-2.6 vs 43.15+/-4.7, P<0.01). Compared with the vehicle-treated I/R, EPO improved tissue injury; decreased the intensity of eNOS immunolabelling (1.6+/-0.24 vs 3+/-0.4, P<0.05), the number of TUNEL-positive cells (9.2+/-2.7 vs 20.4+/-2.6, P<0.01), and the high histological scores (1+/-0.51 vs 3+/-0.36, P<0.01), and increased catalase activity (42.85+/-6 vs 16.83+/-2.6, P<0.01) when given before ischemia, while it was found to have decreased the levels of MDA (0.483+/-0.025 vs 0.747+/-0.076, P<0.05) and MPO activity (3.86+/-0.76 vs 10.51+/-1.87, P<0.05), intensity of eNOS immunolabelling (1.4+/-0.24 vs 3+/-0.4, P<0.01), the number of TUNEL-positive cells (9.1+/-3 vs 20.4+/-2.6, P<0.01), and the number of high histological scores (1.16+/-0.4 vs 3+/-0.36, P<0.05) when given at the onset of reperfusion. These results demonstrate that EPO protects against intestinal I/R injury in rats by reducing oxidative stress and apoptosis. We attributed this beneficial effect to the antioxidative properties of EPO.
以往研究表明,促红细胞生成素(EPO)对多种组织的缺血/再灌注(I/R)损伤具有保护作用。本研究旨在确定EPO是否能预防I/R诱导的肠道组织损伤。将Wistar大鼠进行肠道缺血(30分钟)和再灌注(60分钟)。在两个不同时间点腹腔注射单剂量EPO(5000 U/kg):要么在缺血开始前5分钟,要么在再灌注开始时。在再灌注期结束时,取出空肠进行检查。通过生化分析评估髓过氧化物酶(MPO)、丙二醛(MDA)和抗氧化防御系统。根据Chiu评分法进行组织学评估。通过免疫组织化学检测内皮型一氧化氮合酶(eNOS)。通过TUNEL染色确定凋亡细胞。与假手术组相比,I/R导致肠道组织损伤(Chiu评分,3±0.36对0.4±0.24,P<0.01),并伴有MDA水平升高(0.747±0.076对0.492±0.033,P<0.05)、MPO活性升高(10.51±1.87对4.3±0.45,P<0.05)、eNOS免疫标记强度升高(3±0.4对1.3±0.33,P<0.05)、TUNEL阳性细胞数量增加(20.4±2.6对4.6±1.2,P<0.001)以及过氧化氢酶活性降低(16.83±2.6对43.15±4.7,P<0.01)。与给予赋形剂的I/R组相比,EPO改善了组织损伤;在缺血前给予时,降低了eNOS免疫标记强度(1.6±0.24对3±0.4,P<0.05)、TUNEL阳性细胞数量(9.2±2.7对20.4±2.6,P<0.01)以及高组织学评分(1±0.51对3±0.36,P<0.01),并增加了过氧化氢酶活性(42.85±6对16.83±2.6,P<0.01);而在再灌注开始时给予时,发现其降低了MDA水平(0.483±0.025对0.747±0.076,P<0.05)、MPO活性(3.86±0.76对10.51±1.87,P<0.05)、eNOS免疫标记强度(1.4±0.24对3±0.4,P<0.01)、TUNEL阳性细胞数量(9.1±3对20.4±2.6,P<0.01)以及高组织学评分数量(1.16±0.4对3±0.36,P<0.05)。这些结果表明,EPO通过降低氧化应激和细胞凋亡来保护大鼠免受肠道I/R损伤。我们将这种有益作用归因于EPO的抗氧化特性。